Federated Hermes, Inc. Enanta Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

$43 Billion
Q4 2024

A detailed history of Federated Hermes, Inc. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 8,534 shares of ENTA stock, worth $63,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,534

Previous 88,128 90.32%

Holding current value

$63,919

Previous $913,000 94.63%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$5.75 - $12.99 $457,665 - $1.03 Million	-79,594 Reduced 90.32%	8,534 $49,000
Q3 2024 Nov 13, 2024	SELL	$10.05 - $16.54 $422 - $694	-42 Reduced 0.05%	88,128 $913,000
Q2 2024 Aug 08, 2024	SELL	$11.43 - $17.02 $22 - $34	-2 Reduced -0.0%	88,170 $1.14 Million
Q1 2024 May 14, 2024	SELL	$10.08 - $17.46 $453,771 - $785,996	-45,017 Reduced 33.8%	88,172 $1.54 Million
Q4 2023 Jan 31, 2024	BUY	$8.18 - $10.78 $1.09 Million - $1.44 Million	133,189 New	133,189 $1.25 Million
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $392 - $518	-7 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $4,430 - $6,334	-108 Reduced 93.91%	7 $1,000
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $1.2 Million - $1.45 Million	-27,376 Reduced 99.58%	115 $5,000
Q1 2021 May 13, 2021	SELL	$41.69 - $54.95 $1.61 Million - $2.12 Million	-38,513 Reduced 58.35%	27,491 $1.36 Million
Q4 2020 Feb 12, 2021	SELL	$41.16 - $47.47 $475,192 - $548,041	-11,545 Reduced 14.89%	66,004 $2.78 Million
Q3 2020 Nov 12, 2020	BUY	$43.36 - $53.53 $19,295 - $23,820	445 Added 0.58%	77,549 $3.55 Million
Q2 2020 Aug 13, 2020	BUY	$46.37 - $57.58 $2.4 Million - $2.98 Million	51,733 Added 203.91%	77,104 $3.87 Million
Q1 2020 May 13, 2020	BUY	$40.22 - $62.0 $1.01 Million - $1.56 Million	25,229 Added 17766.9%	25,371 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $471,191 - $541,605	-8,131 Reduced 98.28%	142 $9,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $2,222 - $3,262	37 Added 0.45%	8,273 $497,000
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $212,193 - $254,083	-2,610 Reduced 24.06%	8,236 $695,000
Q1 2019 May 10, 2019	SELL	$69.08 - $105.66 $2.19 Million - $3.36 Million	-31,761 Reduced 74.54%	10,846 $1.04 Million
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $897,752 - $1.16 Million	-13,725 Reduced 24.36%	42,607 $3.02 Million
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $958,861 - $1.42 Million	-11,220 Reduced 16.61%	56,332 $4.81 Million
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $5.52 Million - $8.13 Million	67,501 Added 132354.91%	67,552 $7.83 Million
Q1 2018 May 09, 2018	BUY	$57.91 - $92.15 $2,953 - $4,699	51 New	51 $4,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

19.7M

Call Options Held

9.7K

Put Options Held

12.4K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $155M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Enanta Pharmaceuticals Inc Transaction History